Cas no 78155-78-9 (N-hydroxy-1H-Indazole-3-carboxamide)
N-hydroxy-1H-Indazole-3-carboxamide Chemical and Physical Properties
Names and Identifiers
-
- N-hydroxy-1H-Indazole-3-carboxamide
- DTXSID501293415
- 78155-78-9
- EN300-1724019
-
- Inchi: 1S/C8H7N3O2/c12-8(11-13)7-5-3-1-2-4-6(5)9-10-7/h1-4,13H,(H,9,10)(H,11,12)
- InChI Key: QNYDFCGJGMCOAP-UHFFFAOYSA-N
- SMILES: O=C(C1C2C=CC=CC=2NN=1)NO
Computed Properties
- Exact Mass: 177.053826475g/mol
- Monoisotopic Mass: 177.053826475g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 3
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 13
- Rotatable Bond Count: 1
- Complexity: 210
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 0.7
- Topological Polar Surface Area: 78?2
N-hydroxy-1H-Indazole-3-carboxamide Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| A2B Chem LLC | AX28282-2.5g |
N-Hydroxy-1h-indazole-3-carboxamide |
78155-78-9 | 95% | 2.5g |
$1772.00 | 2024-04-19 | |
| A2B Chem LLC | AX28282-5g |
N-Hydroxy-1h-indazole-3-carboxamide |
78155-78-9 | 95% | 5g |
$2607.00 | 2024-04-19 | |
| A2B Chem LLC | AX28282-10g |
N-Hydroxy-1h-indazole-3-carboxamide |
78155-78-9 | 95% | 10g |
$3848.00 | 2024-04-19 | |
| A2B Chem LLC | AX28282-50mg |
N-Hydroxy-1h-indazole-3-carboxamide |
78155-78-9 | 95% | 50mg |
$243.00 | 2024-04-19 | |
| A2B Chem LLC | AX28282-100mg |
N-Hydroxy-1h-indazole-3-carboxamide |
78155-78-9 | 95% | 100mg |
$344.00 | 2024-04-19 | |
| A2B Chem LLC | AX28282-250mg |
N-Hydroxy-1h-indazole-3-carboxamide |
78155-78-9 | 95% | 250mg |
$475.00 | 2024-04-19 | |
| A2B Chem LLC | AX28282-500mg |
N-Hydroxy-1h-indazole-3-carboxamide |
78155-78-9 | 95% | 500mg |
$726.00 | 2024-04-19 | |
| A2B Chem LLC | AX28282-1g |
N-Hydroxy-1h-indazole-3-carboxamide |
78155-78-9 | 95% | 1g |
$922.00 | 2024-04-19 | |
| Enamine | EN300-1724019-0.05g |
N-hydroxy-1H-indazole-3-carboxamide |
78155-78-9 | 95% | 0.05g |
$197.0 | 2023-09-20 | |
| Enamine | EN300-1724019-0.1g |
N-hydroxy-1H-indazole-3-carboxamide |
78155-78-9 | 95% | 0.1g |
$293.0 | 2023-09-20 |
N-hydroxy-1H-Indazole-3-carboxamide Related Literature
-
Andreas Nenning,Manuel Holzmann,Jürgen Fleig,Alexander K. Opitz Mater. Adv., 2021,2, 5422-5431
-
Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
-
Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
-
Jason Wan Lab Chip, 2020,20, 4528-4538
-
Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544
Additional information on N-hydroxy-1H-Indazole-3-carboxamide
Introduction to N-hydroxy-1H-Indazole-3-carboxamide (CAS No. 78155-78-9)
N-hydroxy-1H-Indazole-3-carboxamide is a significant compound in the realm of pharmaceutical chemistry, recognized for its versatile applications in drug discovery and molecular research. With a Chemical Abstracts Service (CAS) number of 78155-78-9, this compound has garnered attention due to its structural uniqueness and potential biological activities. The molecule, featuring a hydroxy group attached to an indazole core with a carboxamide substituent, presents an intriguing framework for medicinal chemists to explore.
The indazole scaffold is a prominent heterocyclic structure that has been extensively studied for its role in various pharmacological applications. Its aromatic system, combined with nitrogen atoms at specific positions, contributes to the compound's ability to interact with biological targets such as enzymes and receptors. The presence of the hydroxy group further enhances its reactivity, making it a valuable intermediate in synthesizing more complex molecules. Additionally, the carboxamide moiety introduces polarity and potential hydrogen bonding capabilities, which are crucial for drug-like properties.
In recent years, N-hydroxy-1H-Indazole-3-carboxamide has been explored in the development of novel therapeutic agents. Its structural features make it a promising candidate for targeting various diseases, including cancer and inflammatory disorders. Researchers have leveraged its chemical properties to design derivatives with enhanced efficacy and selectivity. For instance, studies have demonstrated its potential in modulating pathways involving kinases and other critical enzymes implicated in disease progression.
One of the most compelling aspects of N-hydroxy-1H-Indazole-3-carboxamide is its role as a precursor in the synthesis of more complex bioactive molecules. The hydroxy group allows for further functionalization via oxidation or reduction reactions, while the carboxamide moiety can be used to link other pharmacophores through amide bond formation. This flexibility makes it an indispensable tool in synthetic organic chemistry, particularly in medicinal chemistry laboratories.
The compound's relevance extends beyond academic research; it has also found applications in industrial settings where high-purity intermediates are required for large-scale drug production. Its stability under various reaction conditions and compatibility with standard synthetic protocols make it a preferred choice for pharmaceutical manufacturers seeking reliable building blocks for drug candidates.
Recent advancements in computational chemistry have further highlighted the importance of N-hydroxy-1H-Indazole-3-carboxamide. Molecular modeling studies have revealed insights into its binding interactions with biological targets, providing valuable data for rational drug design. These computational approaches have enabled researchers to predict and optimize the compound's pharmacokinetic properties, thereby accelerating the development of novel therapeutics.
The synthesis of N-hydroxy-1H-Indazole-3-carboxamide itself is a testament to the ingenuity of modern organic synthesis techniques. The process typically involves multi-step reactions starting from readily available precursors, showcasing the efficiency and precision of contemporary synthetic methodologies. This accessibility has contributed to its widespread use in both academic and industrial research settings.
In conclusion, N-hydroxy-1H-Indazole-3-carboxamide (CAS No. 78155-78-9) stands as a cornerstone compound in pharmaceutical chemistry due to its structural complexity and functional versatility. Its applications span from academic research to industrial-scale drug production, underscoring its importance in modern medicine. As research continues to uncover new therapeutic possibilities, this compound will undoubtedly remain at the forefront of drug discovery efforts.
78155-78-9 (N-hydroxy-1H-Indazole-3-carboxamide) Related Products
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)